Search Results - "Fofana, F"

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis by Puelles, J., Fofana, F., Rodriguez, D., Silverberg, J.I., Wollenberg, A., Dias Barbosa, C., Vernon, M., Chavda, R., Gabriel, S., Piketty, C.

“…Summary Background Sleep disturbance (SD) is an important part of the burden of atopic dermatitis (AD), but patient‐reported outcomes that are easy to…”
Get full text

Immunopathogenesis of idiopathic nephrotic syndrome by Savas, B., Fofana, F., Le Gouvello, S., Pawlak, A., Sahali, D., Ollero, M.

Get full text

Responder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab by D'Angelo, S.P., Fofana, F., Schlichting, M., Henry-Szatkowski, M., Hennessy, M., Bharmal, M.

Get full text

Coupling of Single Molecule, Long Read Sequencing with IMGT/HighV-QUEST Analysis Expedites Identification of SIV gp140-Specific Antibodies from scFv Phage Display Libraries by Han, Seung Yub, Antoine, Alesia, Howard, David, Chang, Bryant, Chang, Woo Sung, Slein, Matthew, Deikus, Gintaras, Kossida, Sofia, Duroux, Patrice, Lefranc, Marie-Paule, Sebra, Robert P, Smith, Melissa L, Fofana, Ismael Ben F

“…The simian immunodeficiency virus (SIV)/macaque model of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome pathogenesis is critical for…”
Get full text

geminivirus-induced gene silencing system for gene function validation in cassava by Fofana, I.B.F, Sangare, A, Collier, R, Taylor, C, Fauquet, C.M

“…We have constructed an African cassava mosaic virus (ACMV) based gene-silencing vector as a reverse genetics tool for gene function analysis in cassava. The…”
Get full text

PGI37 Finalisation and Psychometric Validation of a new Questionnaire Measuring Patient Satisfaction With Anti-TNF Treatments in Severe Crohn's Disease by Arnould, B, Fofana, F, Gilet, H, Colombel, J.F, Faure, P, Hagège, H, Nachury, M, Nahon, S, Tucat, G, Vandromme, L, Clerson, P, d'Hondt, O, Cazala Telinge, I, Hauville, C, Thibout, E

Get full text

PCR78 Establishing Meaningful Change Thresholds for EORTC QLQ-CLL17 Domain Scores: An Analysis Based on the TRANSCEND CLL 004 Study in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma by Eliason, L., Fofana, F., Wang, L., Riedell, P.A., Guo, S.

Get full text

Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design: An Example in A Rare Cardiac Clinical Trial by Marrel, A, Fofana, F, Guillemin, I

Get full text

PRM25 - Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design: An Example in A Rare Cardiac Clinical Trial by Marrel, A, Fofana, F, Guillemin, I

Get full text

1282PResponder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab by D'Angelo, S P, Fofana, F, Schlichting, M, Henry-Szatkowski, M, Hennessy, M, Bharmal, M

Get full text

PRM233 - Methods For Analyzing Patient-Reported Outcomes In Oncology Trials by Williams, P, Fofana, F, de la Loge, C, Arnould, B

Get full text

Methods For Analyzing Patient-Reported Outcomes In Oncology Trials by Williams, P, Fofana, F, de la Loge, C, Arnould, B

Get full text

PSYCHOMETRIC VALIDATION OF THE FACT-M QUESTIONNAIRE IN PATIENTS WITH MERKEL CELL CARCINOMA by Bharmal, M, Fofana, F, Barbosa, C Dias, Mahnke, L, Schlichting, M

“…OBJECTIVES: Assessment of patient-reported outcomes in oncology clinical trials is required to demonstrate treatment benefit from a patient's perspective. No…”
Get full text

Monitoring Severity of Respiratory Syncytial Virus (RSV) in Infants and Young Children Using the Pediatric RSV Electronic Severity and Outcome Rating System (PRESORS): Results of Initial Quantitative Validation by de la Loge, Christine, Fofana, Fatoumata, Williams, Paul, Rusch, Sarah, Stevens, Marita, Scott, Jane

“…Purpose: PRESORS ClinRO completed by clinicians and ObsRO completed by caregivers were developed to characterize the clinical course of respiratory syncytial…”
Get full text

Identification of a defective molecule derived from DNA-A of the bipartite begomovirus of East African cassava mosaic virus by Ndunguru, J, Legg, J.P, Fofana, I.B.F, Aveling, T.A.S, Thompson, G, Fauquet, C.M

“…Geminivirus defective interfering DNAs arise spontaneously in mechanically inoculated test plants, and have previously been found with DNA‐B of the bipartite…”
Get full text

D103 COPD: FOCUS ON RESEARCH AND PATIENT CARE: Does Lung Function Change Correlate With Patient Reported Outcomes (pros) In Stable Chronic Obstructive Pulmonary Disease (COPD)? by De La Loge, C, Tugaut, B, Hennig, M, Fofana, F, Tschiesner, U, Ismaila, A, Vahdati-Bolouri, M, Lambert, J, Punekar, Y S

Get full text

GARCH option pricing with implied volatility by Fofana, N'zue F., Wade Brorsen, B.

“…Generalized autoregressive conditional heteroskedasticity (GARCH) option pricing models (OPM) with historical volatility have proven superior to the…”
Get full text

PIN117 - Scoring and Measurement Properties of a Tool to Assess Primary Care Physicians’ Engagement in and Perceived Barriers to Vaccination: the ‘Determinant of Intentions of Vaccination’ (Diva©) Questionnaire by Arnould, B, Arnould, P, Benmedjahed, K, Coindard, G, Denis, F, Duhot, D, Gallais, J, Martinez, L, Raineri, F, Seyler, D, Tugaut, B, Fofana, F

Get full text

Scoring and Measurement Properties of a Tool to Assess Primary Care Physicians’ Engagement in and Perceived Barriers to Vaccination: the ‘Determinant of Intentions of Vaccination’ (Diva©) Questionnaire by Arnould, B, Arnould, P, Benmedjahed, K, Coindard, G, Denis, F, Duhot, D, Gallais, J, Martinez, L, Raineri, F, Seyler, D, Tugaut, B, Fofana, F

Get full text

Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes by Fofana, Ismael Ben F., Colantonio, Arnaud D., Reeves, R. Keith, Connole, Michelle A., Gillis, Jacqueline M., Hall, Laura R., Sato, Shuji, Audin, Craig R., Evans, David T., Shida, Hisatoshi, Johnson, R. Paul, Johnson, Welkin E.

“…SIV infection of macaques is the most widely employed model for preclinical AIDS vaccine and pathogenesis research. In macaques, high-titer virus-specific…”
Get full text